- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
The Flowr Corporation (TSXV:FLWR) has announced that it will commence trading today, September 26, on the TSX Venture Exchange under the ticker symbol FLWR.
The Flowr Corporation (TSXV:FLWR) has announced that it will commence trading today, September 26, on the TSX Venture Exchange under the ticker symbol FLWR.
The company was recently featured in a Forbes article, where the publication addressed the company’s work leading up to the listing. In anticipation of today’s news, the company raised $27 million and took part in a reverse takeover. According to Flowr CEO Vinay Tolia, they will use the momentum from the listing to “focus on executing [their] business plan.”
The company is led by a team that holds a wealth of experience, including its president, Tom Flow, who co-founded the medical cannabis company MedReleaf, which was acquired by Aurora Cannabis (TSX:ACB) for $2.51 billion earlier this year. The company believes that this experience will help carry them forward in a growing market. “The people who are just getting into the game – they haven’t had their 10,000 hours,” Tolia is quoted as saying. “They’re making mistakes – things that these guys have gone through 10 years ago.”
Flowr is poised to enter the growing Canadian cannabis market with its flagship cultivation site in Kelowna, BC. “The 85,000-square-foot facility is expected to produce more than 13 tons of cannabis annually once it’s fully operational in 2019. The company will serve both the medical and adult-use markets.” The company is using proprietary cultivation systems that eliminate the need for irradiation, which has been proven to cause terpene degradation.
To read the full article, click here.
Click here to connect with The Flowr Corporation (TSXV: FLWR) for an Investor Presentation.
Source: www.forbes.com
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.